期刊論文1. | Martin SJ、Jung R、Garvin CG.(2001)。A risk-benefit assessment of levofloxacin in respiratory, skin and skin structure, and urinary tract infections。Drug Saf,24,199-222。 |
2. | Shams WE、Evans ME.(2005)。Guide to selection of fluoroquinolones in patients with lower respiratory tract infections。Drugs,65,949-991。 |
3. | Sprandel, KA、Rodvold, KA(2003)。Safety and tolerability of fluoroquinolones。Clin Cornerstone,Suppl 3,29-36。 |
4. | Lewis GBH、Hecker JF.(1985)。Infusion thrombophlebitis。Br J Anaesth,57,220-233。 |
5. | Peruccä R、Micek J.(1993)。Treatment of infusion-related phlebitis: review and nursing protocol。J Intraven Nurs,16,282-286。 |
6. | 郭憲華、施秀(19971200)。如何預防靜脈炎。院內感染控制雜誌,7(6),357-359。 延伸查詢 |
7. | Vorbach H、Weigel G、Robibaro B.(1997)。Endothelial cell compatibility of fluoroquinolone solutions for intravenous use。Int J Clin Pharmacol Ther,35,235-238。 |
8. | Armbruster, C、Robibaro, B、Griesmacher, A.(2000)。Endothelial cell compatibility of trovafloxacin and levofloxacin for intravenous use。J Antimicrob Chemother,45,533-535。 |
9. | 林碧珠、戴玉慈(19760700)。引起輸注性靜脈炎之原因--探討性之研究。護理雜誌,23(3),42-49。 延伸查詢 |
10. | 顧艷秋(19970100)。周邊靜脈留置導管引發的靜脈炎相關因素之探討。公共衛生,23(4),213-224。 延伸查詢 |